Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions for Turning Point Therapeutics, Inc. (TPTX)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
TPTXTurning Point Therapeutics, Inc.George SimeonDirectorAug 17, 2022Option Exercise$76.002,253,660171,278,1600Aug 17, 2022, 04:40 PM
TPTXTurning Point Therapeutics, Inc.Alles Mark JDirectorAug 17, 2022Option Exercise$76.002,000152,0000Aug 17, 2022, 04:32 PM
TPTXTurning Point Therapeutics, Inc.TOMBESI PAOLOEVP & Chief Financial OfficerAug 17, 2022Option Exercise$76.0029,7782,263,1280Aug 17, 2022, 04:31 PM
TPTXTurning Point Therapeutics, Inc.Hirmand MohammadEVP and Chief Medical OfficerAug 17, 2022Option Exercise$76.0041,2843,137,5840Aug 17, 2022, 04:26 PM
TPTXTurning Point Therapeutics, Inc.Countouriotis AthenaPresident & CEOAug 17, 2022Option Exercise$76.00110,9598,432,8840Aug 17, 2022, 04:23 PM
TPTXTurning Point Therapeutics, Inc.TOMBESI PAOLOEVP & Chief Financial OfficerJul 27, 2022Sale$74.941,18388,65428,700Jul 29, 2022, 04:18 PM
TPTXTurning Point Therapeutics, Inc.Reich SiegfriedEVP & Chief Scientific OfficerFeb 09, 2022Sale$36.3039714,4113,448Feb 11, 2022, 06:10 PM
TPTXTurning Point Therapeutics, Inc.Partridge Andrew JohnEVP & Chief Commercial OfficerFeb 09, 2022Sale$36.302218,02222,078Feb 11, 2022, 06:09 PM
TPTXTurning Point Therapeutics, Inc.North AnnetteEVP & General CounselFeb 09, 2022Sale$36.3066924,28511,696Feb 11, 2022, 06:09 PM
TPTXTurning Point Therapeutics, Inc.Hirmand MohammadEVP & Chief Medical OfficerFeb 09, 2022Sale$36.3066924,2856,838Feb 11, 2022, 06:08 PM
TPTXTurning Point Therapeutics, Inc.Countouriotis AthenaPresident & CEOFeb 09, 2022Sale$36.302,971107,84747,930Feb 11, 2022, 06:07 PM
TPTXTurning Point Therapeutics, Inc.North AnnetteEVP, General Counsel & Secty.Aug 30, 2021Option Exercise$48.5020,000970,00022,365Aug 31, 2021, 05:26 PM
TPTXTurning Point Therapeutics, Inc.Partridge Andrew JohnEVP & Chief Commercial OfficerJul 14, 2021Sale$74.901,869139,98821,767Jul 15, 2021, 05:53 PM
TPTXTurning Point Therapeutics, Inc.Alles Mark JDirectorJun 21, 2021Buy$81.342,000162,6802,000Jun 21, 2021, 09:14 PM
TPTXTurning Point Therapeutics, Inc.Baker Brian LeeSVP of Finance and Admin.Mar 23, 2021Sale$52.6656,8702,994,98832,551Mar 24, 2021, 09:54 PM
TPTXTurning Point Therapeutics, Inc.North AnnetteEVP, General Counsel & Secty.Mar 08, 2021Option Exercise$63.4040,0002,535,93926,483Mar 09, 2021, 07:26 PM
TPTXTurning Point Therapeutics, Inc.Reich SiegfriedEVP & Chief Scientific OfficerMar 04, 2021Sale$78.1671,1005,557,07939,395Mar 05, 2021, 08:56 PM
TPTXTurning Point Therapeutics, Inc.Countouriotis AthenaPresident & CEOFeb 09, 2021Sale$70.9451,3323,641,60775,861Feb 11, 2021, 08:28 PM
TPTXTurning Point Therapeutics, Inc.Countouriotis AthenaPresident & CEOFeb 10, 2021Sale$69.7550,7843,542,37175,587Feb 11, 2021, 08:28 PM
TPTXTurning Point Therapeutics, Inc.Countouriotis AthenaPresident & CEOFeb 11, 2021Sale$70.2917,8841,257,06059,137Feb 11, 2021, 08:28 PM
TPTXTurning Point Therapeutics, Inc.North AnnetteEVP, General Counsel & Secty.Feb 02, 2021Sale$73.4418,0321,324,2619,016Feb 02, 2021, 09:50 PM
TPTXTurning Point Therapeutics, Inc.North AnnetteEVP, General Counsel & Secty.Feb 01, 2021Sale$70.3231,9682,248,10215,984Feb 02, 2021, 09:50 PM
TPTXTurning Point Therapeutics, Inc.Larson YiEVP & Chief Financial OfficerFeb 01, 2021Sale$88.8331,4042,789,48418,406Feb 02, 2021, 09:47 PM
TPTXTurning Point Therapeutics, Inc.Larson YiEVP & Chief Financial OfficerFeb 02, 2021Sale$92.0928,5962,633,33417,002Feb 02, 2021, 09:47 PM
TPTXTurning Point Therapeutics, Inc.Baker Brian LeeSVP of Finance and Admin.Jan 07, 2021Sale$66.2259,6763,952,00932,246Jan 08, 2021, 09:08 PM
TPTXTurning Point Therapeutics, Inc.Hirmand MohammadEVP and Chief Medical OfficerJan 05, 2021Sale$87.362,506218,9371,537Jan 05, 2021, 09:03 PM
TPTXTurning Point Therapeutics, Inc.Hirmand MohammadEVP and Chief Medical OfficerJan 04, 2021Sale$88.1617,7941,568,7699,331Jan 05, 2021, 09:03 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorJun 09, 2020Sale$65.819,500625,194549,471Jun 10, 2020, 05:26 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorJun 04, 2020Sale$64.8018,5001,198,891603,483Jun 08, 2020, 08:26 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorJun 05, 2020Sale$64.2118,5001,187,868583,281Jun 08, 2020, 08:26 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorJun 08, 2020Sale$63.4518,5001,173,888566,511Jun 08, 2020, 08:26 PM
TPTXTurning Point Therapeutics, Inc.George SimeonDirectorMay 21, 2020Buy$60.0083,3334,999,9802,253,660May 26, 2020, 05:57 PM
TPTXTurning Point Therapeutics, Inc.Countouriotis AthenaPresident & CEOMay 21, 2020Buy$60.004,166249,96026,872May 26, 2020, 05:55 PM
TPTXTurning Point Therapeutics, Inc.GLAXOSMITHKLINE PLCDirectorMay 21, 2020Buy$60.0083,3334,999,9802,253,660May 26, 2020, 04:17 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorMay 19, 2020Sale$57.737,000404,108625,183May 21, 2020, 07:05 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorMay 20, 2020Sale$60.157,000421,045618,883May 21, 2020, 07:05 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorMay 21, 2020Sale$59.657,000417,550605,483May 21, 2020, 07:05 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorMay 08, 2020Sale$53.8611,500619,351637,153May 12, 2020, 08:09 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorMay 05, 2020Sale$54.0218,500999,426689,385May 07, 2020, 06:52 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorMay 06, 2020Sale$52.9418,500979,323668,811May 07, 2020, 06:52 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorMay 07, 2020Sale$52.8618,500977,886651,077May 07, 2020, 06:52 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorApr 24, 2020Sale$51.017,000357,090697,170Apr 24, 2020, 08:20 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorApr 22, 2020Sale$51.787,000362,481708,683Apr 24, 2020, 08:20 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorApr 23, 2020Sale$51.927,000363,408704,183Apr 24, 2020, 08:20 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorApr 09, 2020Sale$47.4511,500545,648720,609Apr 13, 2020, 07:16 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorApr 13, 2020Sale$50.0570835,438714,891Apr 13, 2020, 07:16 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorApr 07, 2020Sale$44.8618,500829,998759,091Apr 08, 2020, 07:21 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorApr 08, 2020Sale$46.2518,500855,604738,797Apr 08, 2020, 07:21 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorApr 06, 2020Sale$43.5118,500804,874780,991Apr 08, 2020, 07:21 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorMar 26, 2020Sale$46.0311,500529,372786,991Mar 27, 2020, 06:27 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorMar 24, 2020Sale$41.957,000293,655817,083Mar 25, 2020, 06:47 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorMar 25, 2020Sale$45.4217,792808,090809,283Mar 25, 2020, 06:47 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorMar 23, 2020Sale$38.397,000268,706824,483Mar 25, 2020, 06:47 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorMar 10, 2020Sale$42.2818,500782,113862,283Mar 12, 2020, 08:40 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorMar 11, 2020Sale$41.2018,500762,202846,183Mar 12, 2020, 08:40 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorMar 12, 2020Sale$36.087,000252,528829,783Mar 12, 2020, 08:40 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorFeb 24, 2020Sale$53.707,000375,930884,383Feb 26, 2020, 08:20 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorFeb 25, 2020Sale$51.357,000359,478879,858Feb 26, 2020, 08:20 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorFeb 26, 2020Sale$51.437,000360,014871,983Feb 26, 2020, 08:20 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorDec 27, 2019Option Exercise$4.7138,080179,456873,519Feb 26, 2020, 08:18 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorDec 30, 2019Option Exercise$5.1216,86486,344890,383Feb 26, 2020, 08:18 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorJun 27, 2019Option Exercise$5.1254,220277,606835,439Feb 26, 2020, 08:18 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorFeb 13, 2020Sale$61.8411,500711,137792,519Feb 14, 2020, 04:22 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorFeb 10, 2020Sale$62.9418,5001,164,482838,968Feb 12, 2020, 07:31 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorFeb 11, 2020Sale$63.2318,5001,169,667815,469Feb 12, 2020, 07:31 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirectorFeb 12, 2020Sale$65.9218,5001,219,594805,419Feb 12, 2020, 07:31 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerJan 28, 2020Sale$58.367,000408,529858,151Jan 29, 2020, 07:37 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerJan 29, 2020Sale$58.737,000411,104851,820Jan 29, 2020, 07:37 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerJan 27, 2020Sale$57.667,000403,652867,620Jan 29, 2020, 07:37 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerJan 15, 2020Sale$53.1211,500610,853870,819Jan 17, 2020, 05:10 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerJan 10, 2020Sale$57.6818,5001,067,161935,919Jan 14, 2020, 07:17 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerJan 13, 2020Sale$52.8718,500978,073909,813Jan 14, 2020, 07:17 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerJan 14, 2020Sale$53.5618,500990,811895,829Jan 14, 2020, 07:17 PM
TPTXTurning Point Therapeutics, Inc.Countouriotis AthenaPresident & CEODec 10, 2019Option Exercise$31.1370621,97622,706Jan 08, 2020, 04:24 PM
TPTXTurning Point Therapeutics, Inc.Baker Brian LeeVP of Finance and Admin.Dec 10, 2019Option Exercise$31.132166,7233,016Jan 08, 2020, 04:12 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerDec 18, 2019Sale$59.2018,5001,095,170980,989Dec 20, 2019, 06:29 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerDec 19, 2019Sale$61.0918,5001,130,257964,819Dec 20, 2019, 06:29 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerDec 20, 2019Sale$63.4011,500729,150946,319Dec 20, 2019, 06:29 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerDec 17, 2019Sale$61.3218,5001,134,374999,619Dec 17, 2019, 09:09 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerDec 13, 2019Sale$55.7511,500641,1691,019,119Dec 17, 2019, 09:09 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerDec 16, 2019Sale$58.3511,500671,0771,014,119Dec 17, 2019, 09:09 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerDec 10, 2019Sale$54.5811,500627,6311,058,019Dec 12, 2019, 07:54 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerDec 11, 2019Sale$52.9411,500608,7871,040,291Dec 12, 2019, 07:54 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerDec 12, 2019Sale$54.1111,500622,2911,037,219Dec 12, 2019, 07:54 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerDec 05, 2019Sale$51.9556,1102,914,9361,157,939Dec 09, 2019, 08:44 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerDec 06, 2019Sale$50.7750,8902,583,5881,086,482Dec 09, 2019, 08:44 PM
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerDec 09, 2019Sale$55.3211,500636,2291,069,219Dec 09, 2019, 08:44 PM
TPTXTurning Point Therapeutics, Inc.GLAXOSMITHKLINE PLCDirectorSep 10, 2019Buy$45.00177,7777,999,9652,170,327Sep 12, 2019, 04:18 PM
TPTXTurning Point Therapeutics, Inc.George SimeonDirectorSep 10, 2019Buy$45.00177,7777,999,9652,170,327Sep 11, 2019, 06:42 PM
TPTXTurning Point Therapeutics, Inc.Larson YiEVP & Chief Financial OfficerSep 10, 2019Buy$45.002,22299,9902,222Sep 11, 2019, 04:16 PM
TPTXTurning Point Therapeutics, Inc.Countouriotis AthenaPresident & CEOSep 10, 2019Buy$45.0010,000450,00022,000Sep 11, 2019, 04:15 PM
TPTXTurning Point Therapeutics, Inc.Chen BihuaDirectorMay 14, 2019Option Exercise$2.1923,26851,0623,122,367May 16, 2019, 04:15 PM
TPTXTurning Point Therapeutics, Inc.Cormorant Asset Management, LP10% OwnerApr 22, 2019Buy$18.00400,0007,200,0003,099,099Apr 25, 2019, 04:08 PM
TPTXTurning Point Therapeutics, Inc.GLAXOSMITHKLINE PLCDirectorApr 22, 2019Buy$18.00325,0005,850,0001,992,550Apr 24, 2019, 07:28 PM
TPTXTurning Point Therapeutics, Inc.ORBIMED ADVISORS LLCDirectorApr 22, 2019Buy$18.00360,0006,480,0002,027,550Apr 24, 2019, 06:16 PM
TPTXTurning Point Therapeutics, Inc.Lu HongboDirectorApr 22, 2019Buy$18.0060,0001,080,0001,727,550Apr 24, 2019, 06:11 PM
TPTXTurning Point Therapeutics, Inc.GORDON CARL LDirectorApr 22, 2019Buy$18.00360,0006,480,0002,027,550Apr 24, 2019, 06:07 PM
TPTXTurning Point Therapeutics, Inc.George SimeonDirectorApr 22, 2019Buy$18.00325,0005,850,0001,992,550Apr 24, 2019, 06:04 PM
TPTXTurning Point Therapeutics, Inc.Baker Brian LeeVP of Finance and Admin.Apr 22, 2019Buy$18.002,80050,4002,800Apr 24, 2019, 06:00 PM
TPTXTurning Point Therapeutics, Inc.Countouriotis AthenaPresident & CEOApr 22, 2019Buy$18.0012,000216,00012,000Apr 24, 2019, 05:55 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe